ArticleScientific reports2025
Geographical analysis of malignant tumor incidence and treatment in China.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrating migration into cancer geography: spatial clustering of five digestive cancer burden in China.Frontiers in public health · 2026Article
- Subnational situation and public awareness of cancer control in China.World journal of clinical oncology · 2025Review
- From infectious diseases to chronic diseases: the paradigm shift of spatial epidemiology in disease prevention and control.Frontiers in public health · 2025Review
- Trends, Global Comparisons, and Projections of the Burden of Malignant Neoplasm of Bone and Articular Cartilage in China Based on GBD 2021.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant tumors have a severe impact on both patients and their families, and the treatment of malignant tumors is a fundamental component of public health security. Therefore, the issue of malignant tumors is a significant focus in the construction of "Healthy China." There are notable spatial disparities in both the incidence and treatment of malignant tumors in China. Research from a geographical perspective and methodology can help improve local malignant tumor prevention efforts and optimize the national allocation of medical resources. This study collected case samples publicly disclosed by representative malignant tumor mutual assistance platforms in China. The analysis was conducted using prefecture-level regions as the basic unit, applying spatial correlation analysis, geographic detectors, multi-factor regression, geographic inequality decomposition, birth cohort analysis, and other methods. The key findings are as follows: (1) there is a strong spatial aggregation of six high-incidence malignant tumors: respiratory system, digestive system, breast system, reproductive system, urinary system, and endocrine system cancers; (2) natural and human geographical factors have significant explanatory power for the occurrence of malignant tumors, although the influencing factors vary widely among different types of tumors; (3) there are considerable disparities in the distribution of medical resources for malignant tumors across regions, and when patients choose to seek treatment in different locations, they take both geographical distance and the level of medical services into account; (4) the difference in the "treatment occurrence rate" of malignant tumors is substantial between the two sides of the "Hu Huanyong Line"; (5) the degree of inequality in the national "treatment occurrence rate" for malignant tumors is widening with the increasing number of patients born later, but is narrowing with the establishment of new hospitals. Finally, this paper proposes policy recommendations to improve the prevention, control, and treatment of malignant tumors based on local conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.